Ostara Biomedical specialises in developing products to improve success rates of artificial reproduction in mammals. Ostara's innovative technology will be applied to a range of species, including livestock but the first product on the market will be for use in laboratory rodents. This product, ProgenySysTM, will have great impact upon the number of animal in medical research by streamlining generation of transgenic mouse models, which are essential to research into treatments and cures for life-threatening human diseases.
Founded in 2012, Ostara has raised significant investment from investors and grant awards to enable product development and intends to launch ProgenySysTM on the market in 2017.
ProgenySysTM is designed for use by specialist commercial transgenic rodent breeders/suppliers, contract research organisations, breeding facilities within industry and academic institutions worldwide (most universities have an animal facility breeding and are using transgenic rodents).
News from Ostara
Friday, October 23, 2015
Ostara welcomes Dr David Danson as its new Board Chairman and Dr Sarah Field as its new Technical Director. ...Read More
Ostara's New Product
Find out about this revolutionary product - click here